Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bharati Kochar & Hans H. Herfarth. (2018) Teduglutide for the treatment of short bowel syndrome – a safety evaluation. Expert Opinion on Drug Safety 17:7, pages 733-739.
Read now
Read now
Lore Billiauws, Julie Bataille, Vanessa Boehm, Olivier Corcos & Francisca Joly. (2017) Teduglutide for treatment of adult patients with short bowel syndrome. Expert Opinion on Biological Therapy 17:5, pages 623-632.
Read now
Read now
Articles from other publishers (12)
Shiro Nakamura, Motoshi Wada, Tsunekazu Mizushima, Akira Sugita, Yuko Tazuke, Hiroki Ohge, Eri Udagawa, Ryohsuke Ken Suzuki, MinJung Yoon, Andrew Grimm, Szu-Ta Chen & Hiroki Ikeuchi. (2022) Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension. Surgery Today 53:3, pages 347-359.
Crossref
Crossref
Esteban Cruz & Veysel Kayser. 2020. Biologics, Biosimilars, and Biobetters. Biologics, Biosimilars, and Biobetters
47
69
.
Esther Ramos Boluda, Susana Redecillas Ferreiro, Oscar Manrique Moral, Ruth García Romero, Iñaki Irastorza Terradillos, Raquel Nuñez Ramos, Marta Germán Díaz, Begoña Polo Miquel, Inmaculada Vives Piñera, Alida Alcolea Sánchez, Rocío González Sacristán, Marta Bautista Barea & Jose Manuel Moreno Villares. (2020) Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data. Journal of Pediatric Gastroenterology & Nutrition 71:6, pages 734-739.
Crossref
Crossref
F. Joly, D. Seguy, A. Nuzzo, C. Chambrier, P. Beau, F. Poullenot, R. Thibault, L. Armengol Debeir, S. Layec, V. Boehm, J. Lallemand, D. Quilliot & S.M. Schneider. (2020) Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study. Clinical Nutrition 39:9, pages 2856-2862.
Crossref
Crossref
Andrew Ukleja. (2019) Weaning from Parenteral Nutrition. Gastroenterology Clinics of North America 48:4, pages 525-550.
Crossref
Crossref
Sophie Pevny, Sebastian Maasberg, Anja Rieger, Mirjam Karber, Elisabeth Blüthner, Barbora Knappe-Drzikova, Dana Thurmann, Janine Büttner, Karsten-Henrich Weylandt, Bertram Wiedenmann, Verena Alexandra Müller, Hendrik Bläker, Andreas Pascher & Ulrich-Frank Pape. (2019) Experience with teduglutide treatment for short bowel syndrome in clinical practice. Clinical Nutrition 38:4, pages 1745-1755.
Crossref
Crossref
Arturo R. Maldonado†Juan L. Peschiera. 2018. Geriatric Trauma and Acute Care Surgery. Geriatric Trauma and Acute Care Surgery
189
208
.
Andrew Ukleja, Baker Alkhairi, Pablo Bejarano & Amareshwar Podugu. (2017) De Novo Development of Hamartomatous Duodenal Polyps in a Patient With Short Bowel Syndrome During Teduglutide Therapy: A Case Report. Journal of Parenteral and Enteral Nutrition, pages 014860711771848.
Crossref
Crossref
Sara Baldassano, Antonella Amato, Gaetano Felice Caldara & Flavia Mulè. (2016) Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet. Endocrine 54:3, pages 648-656.
Crossref
Crossref
Kazimierz Wiśniewski, Javier Sueiras-Diaz, Guangcheng Jiang, Robert Galyean, Mark Lu, Dorain Thompson, Yung-Chih Wang, Glenn Croston, Alexander Posch, Diane M. Hargrove, Halina Wiśniewska, Régent Laporte, John J. Dwyer, Steve Qi, Karthik Srinivasan, Jennifer Hartwig, Nicky Ferdyan, Monica Mares, John Kraus, Sudarkodi Alagarsamy, Pierre J. M. Rivière & Claudio D. Schteingart. (2016) Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance. Journal of Medicinal Chemistry 59:7, pages 3129-3139.
Crossref
Crossref
Ulrich-Frank Pape, Sebastian Maasberg & Andreas Pascher. (2016) Pharmacological strategies to enhance adaptation in intestinal failure. Current Opinion in Organ Transplantation 21:2, pages 147-152.
Crossref
Crossref
Carsten Keil, Elmar Jäckel, Michael P. Manns & Oliver Bachmann. 2016. Regenerative Medicine - from Protocol to Patient. Regenerative Medicine - from Protocol to Patient
179
221
.